Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia
| Class:Id | LiteratureReference:9699282 |
| _displayName | FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia |
| _timestamp | 2020-09-14 12:17:15 |
| author | [Person:9699281] Peschel, Ines [Person:9699287] Podmirseg, Silvio R [Person:9699286] Taschler, Martin [Person:9649391] Duyster, Justus [Person:9699284] Götze, Katharina S [Person:9699285] Sill, Heinz [Person:9699288] Nachbaur, David [Person:8848457] Jäkel, Heidelinde [Person:8848451] Hengst, Ludger |
| created | [InstanceEdit:9699283] Rothfels, Karen, 2020-09-14 |
| journal | Haematologica |
| pages | 1378-1389 |
| pubMedIdentifier | 28522571 |
| title | FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia |
| volume | 102 |
| year | 2017 |
| (literatureReference) | [DefinedSet:9699531] quizartinib-sensitive FLT3 mutants [plasma membrane] [Homo sapiens] [BlackBoxEvent:9699575] FOXO3-dependent CDKN1B gene expression [Homo sapiens] [Reaction:9699578] Active FLT3 phosphorylates CDKN1B [Homo sapiens] [Reaction:9702510] FLT mutants bind type II TKIs [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27Kip1 in acute myeloid leukemia (9699282)